IPP Bureau
Gland Pharma receives 2 observations under 483 for Pashamylaram facility
By IPP Bureau - August 28, 2023
The company is committed to address the observations and will submit its response to US FDA within the stipulated time
Zydus receives final approval from the USFDA for zinc sulfate injection pharmacy bulk package vials
By IPP Bureau - August 25, 2023
Zinc Sulfate Injection is indicated in adult and paediatric patients as a source of zinc for parenteral nutrition
Lynparza plus abi/pred approved in Japan for treatment of prostate cancer
By IPP Bureau - August 25, 2023
First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent
Roche provides update on Phase III Skyscraper-01 study in PD-L1-high metastatic non-small cell lung cancer
By IPP Bureau - August 25, 2023
SKYSCRAPER-01 is ongoing and the study remains blinded to patients and investigators
Intuitive and Max Healthcare to launch TPO Centre for robotic-assisted surgery
By IPP Bureau - August 25, 2023
Centre aims to train surgeons and other healthcare professionals from India and Southeast Asia in robotic-assisted surgery
India’s MRI systems market to reach $950 million by 2030, forecasts GlobalData
By IPP Bureau - August 25, 2023
India will account for about 18% of the Asia-Pacific (APAC) MRI systems market in 2023
Glenmark Pharmaceuticals USA reaches antitrust settlement with DOJ
By IPP Bureau - August 24, 2023
The company has entered into a three-year Deferred Prosecution Agreement
Briefs: J B Chemicals & Pharmaceuticals updates and Torrent Pharmaceuticals
By IPP Bureau - August 24, 2023
The drug will be manufactured at JB Pharma's formulation manufacturing facility in Panoli, Gujarat
NIH and Exothera partner to produce GMP intranasal vaccine against SARS-CoV-2 for clinical phase I/II trial in Africa and US
By IPP Bureau - August 24, 2023
NIH’s candidate is based on the Adenovirus 4 backbone, largely used as a vector candidate in HIV and influenza vaccine clinical trials
First ABDM Microsite under the 100 Microsites Project by NHA launched in Aizawl
By IPP Bureau - August 24, 2023
Mizoram appoints Youth for Action as the Interfacing Agency for implementing the ABDM Microsite in Aizawl
Vice President Jagdeep Dhankar delivers convocation address at the 48th AIIMS convocation
By IPP Bureau - August 24, 2023
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
Marksans receives USFDA approval for Guaifenesin Extended-Release Tablets
By IPP Bureau - August 23, 2023
Guaifenesin extended-release tablets help to loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
Briefs: Concord Biotech, Cian Healthcare and Eris Lifesciences
By IPP Bureau - August 23, 2023
Eris Lifesciences enters into term loan agreement with Citi Bank
Jupiter Life Line Hospitals raised Rs. 123 crore in pre IPO round
By IPP Bureau - August 23, 2023
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
LEO Pharma to acquire Timber Pharmaceuticals
By IPP Bureau - August 22, 2023
The deal represents a total transaction value of up to $36 million with an initial upfront consideration of $14 million
